Correlation Between Pfizer and Berkshire Grey
Can any of the company-specific risk be diversified away by investing in both Pfizer and Berkshire Grey at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Berkshire Grey into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Berkshire Grey, you can compare the effects of market volatilities on Pfizer and Berkshire Grey and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Berkshire Grey. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Berkshire Grey.
Diversification Opportunities for Pfizer and Berkshire Grey
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Berkshire is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Berkshire Grey in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkshire Grey and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Berkshire Grey. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkshire Grey has no effect on the direction of Pfizer i.e., Pfizer and Berkshire Grey go up and down completely randomly.
Pair Corralation between Pfizer and Berkshire Grey
If you would invest 2,578 in Pfizer Inc on November 29, 2024 and sell it today you would earn a total of 32.13 from holding Pfizer Inc or generate 1.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Pfizer Inc vs. Berkshire Grey
Performance |
Timeline |
Pfizer Inc |
Berkshire Grey |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Pfizer and Berkshire Grey Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Berkshire Grey
The main advantage of trading using opposite Pfizer and Berkshire Grey positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Berkshire Grey can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkshire Grey will offset losses from the drop in Berkshire Grey's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Berkshire Grey vs. Nuburu Inc | Berkshire Grey vs. Laser Photonics | Berkshire Grey vs. JE Cleantech Holdings | Berkshire Grey vs. Reelcause |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |